Tumor Blood Flow Measured by PET Dynamic Imaging of First-Pass 18F-FDG Uptake: A Comparison with 15O-Labeled Water-Measured Blood Flow
暂无分享,去创建一个
Nizar A. Mullani | K. Lance Gould | Bruce J. Barron | James L. Abbruzzese | Roy S. Herbst | R. Herbst | N. Mullani | K. Gould | J. Abbruzzese | R. O'neil | B. Barron | Roger G. O'Neil | K. Gould
[1] Robert B Livingston,et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] E. Halpern,et al. Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology. , 2005, Clinical prostate cancer.
[3] T. Mikkelsen,et al. Angiogenesis in glioma: molecular mechanisms and roadblocks to translation. , 2003, Cancer journal.
[4] I. Mérida,et al. Tumor metabolism: new opportunities for cancer therapy , 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[5] H. Yamauchi,et al. Quantitative Comparison of the Bolus and Steady-State Methods for Measurement of Cerebral Perfusion and Oxygen Metabolism: Positron Emission Tomography Study Using 15O-Gas and Water , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] R. Wahl,et al. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[7] Ludwig G Strauss,et al. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] Tran,et al. 9:30-9:45. First Pass FDG Measured Blood Flow in Tumors: A Comparison with O-15 Labeled Water Measured Blood Flow. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[9] Kazuo Miyasaka,et al. Lung Tumors Evaluated With FDG-PET and Dynamic CT: The Relationship Between Vascular Density and Glucose Metabolism , 2002, Journal of computer assisted tomography.
[10] H. Lyerly,et al. Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy , 2007, Expert opinion on biological therapy.
[11] N. Mullani,et al. Feasibility of measuring first pass extraction and flow with rubidium-82 in the kidneys. , 1990, American journal of physiologic imaging.
[12] G. Parker,et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. , 2004, Radiology.
[13] L. Ellis,et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] U Ruotsalainen,et al. Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] H. Taniguchi,et al. Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using 15O and 18F-deoxyglucose , 2004, Nuclear medicine communications.
[16] Iwao Kanno,et al. Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[17] K. B. Larson,et al. In Vivo Determination of Cerebral Blood Volume with Radioactive Oxygen‐15 in the Monkey , 1975, Circulation research.
[18] A. Harris,et al. Notch signaling from tumor cells: a new mechanism of angiogenesis. , 2005, Cancer cell.
[19] C Cobelli,et al. Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. , 2001, American journal of physiology. Endocrinology and metabolism.
[20] N. Mullani,et al. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] T Inaba,et al. Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography. , 1992, The Journal of urology.
[22] N. Mullani,et al. First-pass measurements of regional blood flow with external detectors. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] Y. Tsushima,et al. Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors. , 2007, Academic radiology.
[24] M J Welch,et al. Blood-brain barrier permeability of 11C-labeled alcohols and 15O-labeled water. , 1976, The American journal of physiology.
[25] L. Ellis,et al. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. Herbst. Therapeutic options to target angiogenesis in human malignancies , 2006, Expert opinion on emerging drugs.
[27] M Schwaiger,et al. Quantitative assessment of tumor metabolism using FDG-PET imaging. , 2000, Nuclear medicine and biology.
[28] Mark Muzi,et al. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] James H Thrall,et al. Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.
[30] N. Mullani,et al. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] H A O'Brien,et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] G. Neufeld,et al. Pro-angiogenic cytokines and their role in tumor angiogenesis , 2006, Cancer and Metastasis Reviews.
[33] N. Mullani,et al. A precise, three-dimensional atlas of myocardial perfusion correlated with coronary arteriographic anatomy , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[34] M. Mintun,et al. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] M. Mintun,et al. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] Hiroshi Watabe,et al. Separation of input function for rapid measurement of quantitative CMRO2 and CBF in a single PET scan with a dual tracer administration method , 2007, Physics in medicine and biology.